Puma Biotechnology (PBYI) Total Debt Growth (1y) (2018 - 2026)
Puma Biotechnology (PBYI) Total Debt Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn | - |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | -79.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79.84% |
| Dec 31, 2025 | -66.41% |
| Sep 30, 2025 | -56.82% |
| Jun 30, 2025 | -49.62% |
| Mar 31, 2025 | -44.04% |
| Dec 31, 2024 | -32.72% |
| Sep 30, 2024 | -21.37% |
| Jun 30, 2024 | -9.99% |
| Mar 31, 2024 | 1.42% |
| Dec 31, 2023 | 1.37% |
| Sep 30, 2023 | 1.33% |
| Jun 30, 2023 | 1.30% |
| Mar 31, 2023 | 1.28% |
| Dec 31, 2022 | 1.25% |
| Sep 30, 2022 | 1.23% |
| Jun 30, 2022 | -2.45% |
| Mar 31, 2022 | -1.84% |
| Dec 31, 2021 | -1.24% |
| Sep 30, 2021 | -0.64% |
| Jun 30, 2021 | -9.67% |